Cart
sales@molnova.com
Thalidomide-NH-C2-PEG3-OH
CAS No. 2140807-23-2
Thalidomide-NH-C2-PEG3-OH( H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl]amino]- )
Catalog No. M28647 CAS No. 2140807-23-2
Thalidomide-NH-C2-PEG3-OH is an E3 ligase ligand-linker conjugate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 134 | In Stock |
|
| 10MG | 199 | In Stock |
|
| 25MG | 316 | In Stock |
|
| 50MG | 442 | In Stock |
|
| 100MG | 593 | In Stock |
|
| 200MG | 775 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThalidomide-NH-C2-PEG3-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionThalidomide-NH-C2-PEG3-OH is an E3 ligase ligand-linker conjugate.
-
DescriptionThalidomide-NH-C2-PEG3-OH is an E3 ligase ligand-linker conjugate.
-
In VitroXZ739, a CRBN-dependent PROTAC BCL-XL degrader with a DC50 value of 2.5 nM in MOLT-4 cells after 16 h treatment. XZ739 also induces cell death through caspase-mediated apoptosis.
-
In Vivo——
-
SynonymsH-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl]amino]-
-
PathwayOthers
-
TargetOther Targets
-
RecptorCYP4A|20-Hydroxyeicosatetraenoic acid(20-HETE) synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2140807-23-2
-
Formula Weight449.45
-
Molecular FormulaC21H27N3O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCCOCCOCCOCCNc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nakamura T, et al. Imidazole derivatives as new potent and selective 20-HETE synthase inhibitors. Bioorg Med Chem Lett. 2004 Jan 19;14(2):333-6.
molnova catalog
related products
-
(R)-ZINC-3573
(R)-ZINC-3573 is a potent and highly selective MRGPRX2 probe that activates endogenous MRGPRX2 in a human mast cell line, inducing degranulation and calcium release.
-
Floramanoside D
Floramanoside D is a flavonol glycoside. Floramanoside D inhibits aldose reductase (IC50 is 2.2 μM), scavenges the 2,2-diphenyl-1-picrylhydrazyl (DPPH) (SC50 is 12.5 μM).
-
Dynorphin A (1-8)
Dynorphin A (1-8) is the predominant opioid peptide identified in placental tissue extracts. Dynorphin A (1-8) is the most likely natural ligand of the kappa receptor. The binding of 3H-Bremazocine to the purified kappa receptor is inhibited by Dynorphin A (1-8) (IC50=303 nM).
